These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5818672)

  • 21. [The metabolism of D-thyroxine and its effect on thyroid function].
    Hüfner M
    Med Klin; 1978 Jan; 73(2):48-53. PubMed ID: 622055
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 23. L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect.
    Young WF; Gorman CA; Jiang NS; Machacek D; Hay ID
    Clin Pharmacol Ther; 1984 Dec; 36(6):781-7. PubMed ID: 6499357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of d-thyroxine sodium on patients with hypercholesterolemia].
    de Oliveira JM
    Hospital (Rio J); 1965 Jul; 68(1):103-14. PubMed ID: 5322314
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical tests with sodium dextrothyroxin in hypercholesteremic patients].
    Zamijovsky M
    Rev Bras Med; 1967 Nov; 24(11):930-3. PubMed ID: 5614497
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)].
    Koschinsky T; Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1974 Mar; 99(11):494-6. PubMed ID: 4365046
    [No Abstract]   [Full Text] [Related]  

  • 27. [D-thyroxine in the treatment of hypercholesterolemia and arteriosclerosis].
    Meriel P; Bounhoure JP; Bayard F
    Angeiologie; 1967; 19(5):73-6. PubMed ID: 5621975
    [No Abstract]   [Full Text] [Related]  

  • 28. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 29. Dextrothyroxine treatment of phosphorylase-kinase deficiency glycogenosis in four boys.
    Garibaldi LR; Borrone C; de Martini I; Battistini E
    Helv Paediatr Acta; 1978 Nov; 33(4-5):435-41. PubMed ID: 280544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PROLONGED ADMINISTRATION OF DEXTROTHYROXINE IN CARDIOVASCULAR PATIENTS.
    ACKERMAN RF
    Memphis Mid South Med J; 1964 Mar; 39():97-102. PubMed ID: 14129033
    [No Abstract]   [Full Text] [Related]  

  • 31. SODIUM DEXTROTHYROXINE THERAPY FOR HYPERCHOLESTEROLEMIA. THREE YEARS OF ADMINISTRATION TO CARDIOVASCULAR SUBJECTS.
    COHEN BM
    Geriatrics; 1964 Aug; 19():585-97. PubMed ID: 14201416
    [No Abstract]   [Full Text] [Related]  

  • 32. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 33. One year of sodium dextrothyroxine therapy for hypercholesterolemia.
    COHEN BM
    Angiology; 1962 Feb; 13():69-74. PubMed ID: 13880229
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of sodium D-thyroxine in the therapy of hypercholesterolemia.
    PEACOCK LB
    J Med Assoc Ga; 1962 Sep; 51():441-5. PubMed ID: 14484730
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of hypercholesterolemia in human subjects with sodium D-thyroxine.
    FIFER WR
    Dis Chest; 1962 Jul; 42():21-8. PubMed ID: 13892797
    [No Abstract]   [Full Text] [Related]  

  • 36. New drugs for the treatment of hypercholesterolemia.
    Hamlin JT
    Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of dextro-thyroxine (choloxin) in cardiovascular disease. Report of a clinical study.
    Reinhardt DJ
    Del Med J; 1968 Mar; 40(3):63-7. PubMed ID: 4868744
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations on sodium D-thyroxine as a hypocholesteremic agent in persons with hypercholesteremia with and without ischemic heart disease.
    WINTERS WL; SOLOFF LA
    Am J Med Sci; 1962 Apr; 243():458-69. PubMed ID: 14007620
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of hypocholesterolemic agents on cholesterol esterification in vitro.
    Schweppe JS; Jungmann RA
    Proc Soc Exp Biol Med; 1971 Feb; 136(2):449-51. PubMed ID: 5544478
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug management of hypercholesterolemia.
    Martz BL
    Am Heart J; 1979 Mar; 97(3):389-98. PubMed ID: 420081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.